IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 307 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,913,172 | $330,657,000 | 12.25% |
| TANAKA CAPITAL MANAGEMENT INC | 84,953 | $4,063,000 | 9.51% |
| Sicart Associates LLC | 280,315 | $13,407,000 | 9.26% |
| DOWLING & YAHNKE LLC | 675,843 | $32,326,000 | 3.62% |
| Opus Point Partners Management, LLC | 77,550 | $3,709,000 | 2.96% |
| Motley Fool Asset Management LLC | 259,000 | $12,388,000 | 2.75% |
| Motley Fool Wealth Management, LLC | 333,604 | $15,956,000 | 1.70% |
| ALTRINSIC GLOBAL ADVISORS LLC | 921,174 | $44,060,000 | 1.63% |
| PINNACLE ASSOCIATES LTD | 1,572,045 | $75,191,000 | 1.52% |
| Sonora Investment Management, LLC | 121,703 | $5,821,054,000 | 1.20% |